New trends in oligotherapeutics

The oligotherapeutics market has expanded in size, disease indications and exploratory molecules in recent years, As oligo API portfolios have grown more diverse, CDMOs are challenged to provide a toolbox of established and new synthesis, purification and scale-up solutions to satisfy complex molecule and customer demands. Join Daniel Bachmann to learn how CDMOs can prepare to meet industry demand.

About the Speaker

Daniel Bachmann

Business Development Manager

Daniel Bachmann, PhD, Business Development Manager Oligonucleotides, is an organic chemist by training and is working in the CDMO industry since 2015. He worked in various positions ranging from process R&D, to product management and project management. Daniel joined Bachem in 2021 where he assumed the role of a customer project manager for Bachem’s Oligonucleotides portfolio and transitioned into business development in the second half of 2023.

Webinars